Formulation strategies for improving drug solubility using solid dispersions

Pharmaceutical Reviews

Volumn 7, Issue 6, 2009, Pages

  Patel, Rajnikant C ^a   Masnoon, Saiyad ^a   Patel, Madhabhai M ^a   Patel, Natvarlal M ^b  

^a Kalol Institute of Pharmacy   (India)

^b Shri B M Shah College of Pharmacy Modasa   (India)

Author keywords

Amorphous state; Bioavailability; Dissolution; Extruding; Lyophilization; Melt agglomeration; Micronization; Solubility

Indexed keywords

DRUG FORMULATION; DRUG SOLUBILITY; FREEZE DRYING; MELTING POINT; REVIEW; SPRAY DRYING; SUPERCRITICAL FLUID;

EID: 77953463363     PISSN: None     EISSN: 19185561     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Ansel H C, Allen L V and Popovich CG. Eds. In; Pharmaceutical dosage forms and drug delivery systems, 7th Edn, Lippincott Williams and Wilkins, 2000, 60-61,66.
2. Ohara T, Kitamura S, Kitagawa T and Terada K. Dissolution mechanism of poorly water- soluble drug from extended solid dispersion system with ethyl cellulose and hydroxypropyl methylcellulose. Int. J. Pharm. 302, 2005, 95-102.
3. Mooter G V den, Weuts I, Rider T D and Blaton N. Evaluation of Inutec SPI as a new carrier in the formulation of solid dispersion for poorly water drugs. Int. J.Pharm. 316, 2006, 1-6.
4. A.A. Noyes, W.R. Whitney, The rate of solution of solid substances in their own solutions, J. Am. Chem. Soc. 19 (1897) 930-934.
5. W. Nernst, Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen, Zeitschrift f. Physik. Chemie 47 (1904) 52-55.
6. E. Galia, E. Nicolaides, D. HoÈrter, R. LoÈbenberg, C. Reppas, J.B. Dressman, Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs, Pharm. Res. 15 (1998) 698-705.
7. Patro S, Himasankar K, Choudhury A A and Rao M E B. Effect of some hydrophilicpolymers on dissolution rate of roxitromycin. Indian J. Pharm. Sci. 67(3), 2005, 334-341.
8. Omaima A S, Mohammed A H, Nagia A M and Ahmed S Z. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersions. AAPS PharmSciTech 7(2), 2006, E1-E9.
9. Hecq J, Deleers M, Fanara D, Vranckx H and Amighi K. Preparation and characterization of nanaocrystals for solubility and dissolution rate enhancement of nifidipine. Int. J. Pharm. 299, 2005,167-177.
10. Takano, Niichiro, Kawashima, Hiroyuki, Shinoda, Yasuo, Inagi and Toshio. Solid dispersion compositions. United States Patent No. 6753330, 2004.
11. Yiyun C, Tongwen X and Rongqiang F. Polyamidoamine dendrimers used as solubility enhances of ketoprofen. Eur. J. Med. Chem. 40, 2005, 1390-1393.
12. Mohan Babu G V M, Prasad D S, and Raman Murthy K V. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug Nimodipine. Int. J. Pharm. 234, 2002, 1-17.
13. Gibaldi M. Ed., In; Biopharmaceutics and clinical pharmacokinetics, 4th Edn, Pharma Book Syndicate, Hyderabad, 2005, 48
14. Tanaka N, Imai K, Okimoto K, Ueda S, Rinta Ibuki Y T, Higaki K and Kimura T. Development of novel sustained-release system, disinmtegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilcadipine (II): In vivo evaluation. Journal of controlled release 122, 2006, 51-56.
15. Duncan Q M C. The mechanism of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231, 2002, 131-144.
16. Hayes, Davis, Morella and Angelo Mario. Pharmaceutical compositions for poorly water-soluble drugs. United States Patent. No. 6881745,2005.
17. J.-O. Henck, U.J. Griesser, A. Burger, Polymorphie von Arzneistoffen, Pharm. Ind. 59 (1997) 165-169.
18. B.C. Hancock, G. Zografi, Characteristics and significance of the amorphous state in pharmaceutical systems (review), J. Pharm. Sci. 86 (1997) 1-12.
19. D. Hoerter, J.B. Dressman, Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract (review), Adv. Drug Delivery Rev. 25 (1997) 3-14.
20. T.Loftsson, M.E. Brewster, Pharmaceutical application of cyclodextrins.Drug solubibilisation and stabilization (review), J.Pharm. Sci. 85 (1996) 1017-1025
21. Zerrouk N, Chemtob C, Arnaud P, Toscani S and Dugue J. In vitro and in vivo evaluation of carbemazepine-PEG 6000 solid dispersions. Int. J. Pharm. 225, 2001, 49-62.
22. Boral A, Sen N, Ghosh L K and Gupta B K. Solid Dispersion technology for controlling drug release and absorption. The eastern pharmacist, April 1995, 141-143.
23. Hasegawa S, Hamaura T, Furuyama N, Kusai A, Yonemochi E and Terada K. Effects of water contents in physical mixture and heating temperature on crystallinity of troglitazone- PVP K 30 solid dispersions prepared by closed melting method. Int. J. Pharm. 302, 2005, 103-112.
24. Nakano, Minoru, Uemura, Toshinobu, Morizane, Shinichi, Okuda, Kiyoshi, Nakata and Keiko. Method of producing a solid dispersion of a sparingly water-soluble drug, nilvadipine. United State Patent No. 5340591, 1994
25. Butler and Mattew J. Method of producing a solid dispersion of a poorly water-soluble drug. United State Patent No. 5985326,1999.
26. Kim Eun-Jung, Chun M K, Jang J S, Lee I H, K R L and Choi H K. Preparation of a solid dispersion of felodipine using a solvent wetting method.
27. Chowdary K P R and R. Hymavathi. Enhancement of dissolution rate of meloxicam. Indian J. Pharm. Sci. April 2001, 150-154.
28. Rao M G, Suneetha R, Reddy P S and Ravi T K. Preparation and evaluation of solid dispersions of naproxen. Indian J. Pharm. Sci. 67(1), 2005,26-29.
29. Mura P, Zerrouk N, Mennini N, Masterly F and Chemtob C. Development and characterization of naproxen solid systems with improved drug dissolution properties. Eur. J. Pharm. Sci. 18, 2003, 67-75.
30. Soniwala M M, Patel P R, Mansuri N S, Parikh R K and Gohel M C. Indian J. Pharm. Sci 67(1), 2005, 61-65.
31. Moneghini M, Carcano A, Zingone G and Perissutti. Studies in dissolution enhancement of atenolol. Int. J. Pharm. 175, 1998, 177-183.
32. Jain R K, Sharma D K, Jain S, Kumar S and Dua J S . Studies on solid dispersions of nimesulide with pregelatinized starch. Biosciences, biotechnology research Asia 3(1a), 2006, 151-153.
33. Suhagia B N, Patel H M, Shah S A, Rathod I and Parmar V K. Acta Pharm 56, 2006, 285-298.
34. Tsinontides S C, Rajniak P, Pham D, Hunke W A, Placek, J and Reynolds S D. Freeze drying- principles and practice for successful scale-up to manufacturing. Int. J. Pharm. 280, No. 1, 2004, 1-16.
35. Betageri G V and Makarla K R. Enhancement of dissolution of Glyburide by solid dispersion and lyophilization techniques. Int. J. Pharm. 126, 1995, 155-160.
36. Yalcin T, Gulgun Y and Gonullu U. Inclusion of ketoprofen with skimmed milk by freeze-drying. Il Farmaco 54, 1999, 648-652.
37. Bandry M B and Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev. Ind. Pharm. 32 (2), 2006 Feb, 141-150.
38. Fathy M and Sheha M. In vitro and in vivo evaluation of an amylobarbitone /hydroxypropyl-betacyclodextrin complex prepared by a freeze-drying method. Pharmazie. 55 (7), 2000 Jul, 513-517.
39. Drooge D J V, Hinrichs W L J, Dickhoff H J, Elli M N A, Visser M R, Zijlastra G S and Frijlink H W. Spray freeze drying to produce a stable 9-tetrahydrocannabino containing inulin based solid dispersion powder suitable for inhalation. Eur. J. Pharm. 26, 2005, 231-240.
40. Seo A, Holm P, Kristensen H G, Schaefer T. The preparation of agglomerates containing solid dispersions of diazepam by melts agglomeration in a high shear mixer. Int. J. Pharm. 259(1-2), 2003 Jun 18, 161-71.
41. Vilhelmsen T, Eliasen H, Schaefer T. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int. J. Pharm. 303(1-2), 2005 Oct 13, 132-142.
42. Vilhelmsen T, Schaefer T. Agglomerate formation and growth mechanisms during melt agglomeration in a rotary processor. Int. J. Pharm. 304 (1- 2), 2005 Nov 4, 152-164.
43. Seo A and Schaefer T. Melt agglomeration with polyethylene glycol beads at a low impeller speed in a high shear mixer. Eur. J. Pharm. Biopharm. 52(3), 2001 Nov, 315-325.
44. Wang L, Cui F D, Hayse T and Sunada H. Preparation and evaluation of solid dispersion for nitrendipine- carbopol and nitrendipine HPMCP systems using twin screw extruder. Chem. Pharm. Bull. 53(10), 2005, 1240-1245
45. Zajc N, Obreza A, Bele M and Srcic S. Physical properties and dissolution behavior of nefidipine/ mannitol solid dispersions prepared by hot melt method. Int. J. Pharm. 291, 2005, 51-58.
46. Nakamichi K, Nakano T, Yasuura H, Izumi S and Kawashima Y. The role of the kneading paddle and the effects of screw revolution speed and water content on the preparation of solid dispersions using a twin-screw extruder. Int. J. Pharm. 241(2), 2002 Jul 25, 203-211.
47. Six K, Verreck G, Peeters J, Brewster M and Van Den Mooter G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow -dissolving polymers. J. Pharm. Sci. 93(1), 2004 Jan, 124-131.
48. Verreck G, Decorte A, Heymans K, Adriaensen J, Liu D, Tomasko D, Arien A, Peeters J, Mooter G V den and Brewster M E. Hot stage extrusion of pamino salicylic acid with EC using CO2 as a temporary plasticizer. Int. J. Pharm. 327, 2006, 45 50.
49. Wu C and Mc Ginity J W. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit RS PO hot-melt extrudates. Eur. J. Pharm. Biopharm. 56(1), 2003 Jul, 95-100.
50. Zajc N, Obreza A, Bele M and Srcic S. Physical properties and dissolution behavior of nefidipine/ mannitol solid dispersions prepared by hot melt method. Int. J. Pharm. 291, 2005,51-58.
51. Six K, Berghmans H, Leuner C, Dressman J, Van Werde K, Mullens J, Benoist L, Thimon M, Meublat L, Verreck G, Peeters J, Brewster M and Van den Mooter G. Characterization of solid dispersions of itraconazole and hydroxypropyl- methylcellulose prepared by melt extrusion, Part II. Pharm. Res. 20(7), 2003 Jul, 1047-1054.
52. Forster A, Hempenstall J, Tucker and Rades T. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Drug Dev. Ind. Pharm. 27(6), 2001 Jul, 549-560.
53. Six K, Daems T, de Hoon J, Van Hecken A, Depre M, Bouche MP, Prinsen P, Verreck G, Peeters J, Brewster ME and Van den Mooter G. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur. J. Pharm. Sci. 24(2-3), 2005 Feb, 179-186.
54. Chronakisa I S, Triantafyllou A O, R Öste. Solidstate characteristics and redispersible properties of powders formed by spray-drying and freeze-drying cereal dispersions of varying (1 3, 1 4)-ß -glucan content. Journal of cereal science 40, 2005, 183-193.
55. Patrice T T, Stephanie B and Hatem F. Preparation of redispersible dry nanocapsules by means of spray drying: Development and characterization. Eur. J. Pharm. Sci. 30, 2007, 124 135.
56. Rankell A S, Lieberman H A and Schiffmann R F. Drying. In: L. Lachman , H.A. Lieberman and J.L.Kanig eds. The theory and practice of industrial pharmacy. 3rd edition, Varghese Publishing house, Bombay, 1987, pp no 61.
57. Weuts I, Kempen D, Verreck G, Decorte A, Heymans K, Peeters J, Brewster M and Mooter G V den. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG 6000 prepared by spray drying. Eur. J. Pharm. Biopharm. 59, 2005, 119-126. Gelucire 44/14 and Labrasol . Il Farmaco 60,2005,777-782.
58. Chauhan B, Shimpi S and Paradkar A. Preparation and evaluation of glibenclamidepolyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 26,2005, 219-230.
59. Ueno Y, Yonemochi E, Tozuka Y, Yamamura S, Oguchi T and Yamamoto K. Characterization of amorphous ursodeoxycholic acid prepared by spray-drying. J. Pharm. Pharmacol. 50(11), 1998 Nov, 1213-1219
60. Chen R, Tagawa M, Hoshi N, Ogura T, Okamoto H and Danjo K. Improved dissolution of an insoluble drug using a 4-fluid nozzle spray-drying technique. Chem. Pharm. Bull. 52(9), 2004 Sep, 1066-1070.
61. Tanno, Fumie, Nishiyama and Yuichi. Process for producing a pharmaceutical solid preparation containing a poorly soluble drug. United states patent No. 6872336.
62. Takeuchi H, Nagira S, Yamamoto H and Kawashima Y. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int. J. Pharm. 293,2005, 155 164.
63. Takeuchi H, Nagira S, Yamamoto H and Kawashima Y. Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Powder technology141, 2004,187-195.
64. Ghebremeskel A N, Vemavarapu C and Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer surfactant combinations using solubility parameters and testing the processability. Int. J. Pharm. 328, 2007, 119-129.
65. Zhang R and Somasundaran P. Advances in adsorption of surfactants and their mixtures at solid/solution interfaces. Advances in colloid and interface science 123-126,2006,213-229.
66. Karatas A, Yüksel N and T Baykara. Improved solubility and dissolution rate of piroxicam usingGelucire 44/14 and Labrasol . Il Farmaco 60, 2005, 777-782.
67. Yükse N, Karatas A, Yalçýn Özkan, Ayhan Savaşer, Sibel A. Özkan and Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 56, 2003, 453-459.
68. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P and Mooter G Van den. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 10, 2000, 311 322.
69. Damian F, Blaton N, Kinget R and Mooter G Van den. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K3. Int. J. Pharm. 244,2002, 87-98.
70. Ivanova R, Lindman B and Alexandridis P. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by poloxamer 407 in water. J of Colloid and Interface Sci. 252, 2002,226 235.
71. Erlandsson B. Stability-indicating changes in poloxamers: the degradation of ethylene oxidepropylene oxide block copolymers at 25 and 40 Co. Polymer degradation and stabili ty 78,2002,571-575.
72. Jannin V, Pochard E and Chambin O. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol® ATO 5. Int. J. Pharm. 309, 2006, 6-15.
73. Chen Y, Zhang G G Z, Neilly J, Marsh K, Mawhinney D and Sanzgiri Y D. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-6. Int. J. Pharm. 286, 2004, 69 80.
74. Ivanova R, Alexandridis P and Lindman B. Interaction of poloxamer block copolymers with co solvents and surfactants. Colloids and Surfaces A: Physicochemical and Engineering Aspects 183 185,2001, 41 53.
75. Joshi H N, Tejwani R W, Davidovich M, Sahasrabudhe V P, Jemal M, Bathala M S, Varia S A and Serajuddin A T M. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol Polysorbate 80 mixture. Int. J. Pharm. 269, 2004, 251-258.
76. Sheen P C, Khetarpal V K, Cariola C.M and Rowlings C E. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int. J. Pharm. 118, 1995, 221-227.
77. Hohman M M, Shin M, Rutledge G and Michael P. Brennera electrospinning and electrically forced jets. II. Applications. Physics of fluids, 13(8), 2001, 2221-2236.
78. Muhrer G, Meier U, Fusaro F, Albano S and Mazzotti M. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions. Int. J. Pharm. 308,2006, 69-83.
79. Majerik V, Charbit G, Badens E, Horv́ath G, Szokonya L, Bosc N and Teillaud E. Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. of Supercritical Fluids 40,2007, 101 110.
80. Taki S, Badens E and Charbit G. Controlled release system formed by supercritical anti-solvent coprecipitation of a herbicide and a biodegradable polymer. J of Supercritical Fluids 21,2001,61 70.
81. Manna L, Banchero M, Solta D, Ferri A, Ronchetii S and Sicrdi S. Impregnation of PVP microparticles with ketoprofen in the presence of supercritical CO2. J of Supercritical Fluids 2006 article in press.
82. Dohrn R, Bertakis E, Behrend O, Voutsas E and Tassios D. Melting point depression by using supercritical CO2 for a novel melt dipersion micronization process. J of Molecular Liquids 131-132, 2007, 53-59.